166 related articles for article (PubMed ID: 38181850)
1. Distinct bile acid alterations in response to a single administration of PFOA and PFDA in mice.
Yu X; Zhang Y; Cogliati B; Klaassen CD; Kumar S; Cheng X; Bu P
Toxicology; 2024 Feb; 502():153719. PubMed ID: 38181850
[TBL] [Abstract][Full Text] [Related]
2. Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers.
Cheng X; Klaassen CD
Toxicol Sci; 2008 Nov; 106(1):37-45. PubMed ID: 18703564
[TBL] [Abstract][Full Text] [Related]
3. Alteration of Bile Acid and Cholesterol Biosynthesis and Transport by Perfluorononanoic Acid (PFNA) in Mice.
Zhang Y; Zhang Y; Klaassen CD; Cheng X
Toxicol Sci; 2018 Mar; 162(1):225-233. PubMed ID: 29112762
[TBL] [Abstract][Full Text] [Related]
4. Perfluorocarboxylic acids induce cytochrome P450 enzymes in mouse liver through activation of PPAR-alpha and CAR transcription factors.
Cheng X; Klaassen CD
Toxicol Sci; 2008 Nov; 106(1):29-36. PubMed ID: 18648086
[TBL] [Abstract][Full Text] [Related]
5. Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid.
Maher JM; Aleksunes LM; Dieter MZ; Tanaka Y; Peters JM; Manautou JE; Klaassen CD
Toxicol Sci; 2008 Dec; 106(2):319-28. PubMed ID: 18757529
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Hox and ParaHox genes by perfluorochemicals in mouse liver.
Zhang Y; Le Y; Bu P; Cheng X
Toxicology; 2020 Aug; 441():152521. PubMed ID: 32534105
[TBL] [Abstract][Full Text] [Related]
7. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
[TBL] [Abstract][Full Text] [Related]
8. Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid.
Eldasher LM; Wen X; Little MS; Bircsak KM; Yacovino LL; Aleksunes LM
Toxicology; 2013 Apr; 306():108-13. PubMed ID: 23435180
[TBL] [Abstract][Full Text] [Related]
9. Dual action of peroxisome proliferator-activated receptor alpha in perfluorodecanoic acid-induced hepatotoxicity.
Luo M; Tan Z; Dai M; Song D; Lin J; Xie M; Yang J; Sun L; Wei D; Zhao J; Gonzalez FJ; Liu A
Arch Toxicol; 2017 Feb; 91(2):897-907. PubMed ID: 27344344
[TBL] [Abstract][Full Text] [Related]
10. Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.
Schlezinger JJ; Puckett H; Oliver J; Nielsen G; Heiger-Bernays W; Webster TF
Toxicol Appl Pharmacol; 2020 Oct; 405():115204. PubMed ID: 32822737
[TBL] [Abstract][Full Text] [Related]
11. Hepatic carboxylesterases are differentially regulated in PPARα-null mice treated with perfluorooctanoic acid.
Wen X; Baker AA; Klaassen CD; Corton JC; Richardson JR; Aleksunes LM
Toxicology; 2019 Mar; 416():15-22. PubMed ID: 30685356
[TBL] [Abstract][Full Text] [Related]
12. Oleanolic acid alters bile acid metabolism and produces cholestatic liver injury in mice.
Liu J; Lu YF; Zhang Y; Wu KC; Fan F; Klaassen CD
Toxicol Appl Pharmacol; 2013 Nov; 272(3):816-24. PubMed ID: 23948738
[TBL] [Abstract][Full Text] [Related]
13. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
[TBL] [Abstract][Full Text] [Related]
14. Characterization of hepatic responses of rat to administration of perfluorooctanoic and perfluorodecanoic acids at low levels.
Kawashima Y; Kobayashi H; Miura H; Kozuka H
Toxicology; 1995 May; 99(3):169-78. PubMed ID: 7610463
[TBL] [Abstract][Full Text] [Related]
15. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
[TBL] [Abstract][Full Text] [Related]
16. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
[TBL] [Abstract][Full Text] [Related]
17. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR.
Rosen MB; Lee JS; Ren H; Vallanat B; Liu J; Waalkes MP; Abbott BD; Lau C; Corton JC
Toxicol Sci; 2008 May; 103(1):46-56. PubMed ID: 18281256
[TBL] [Abstract][Full Text] [Related]
18. Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required.
Filgo AJ; Quist EM; Hoenerhoff MJ; Brix AE; Kissling GE; Fenton SE
Toxicol Pathol; 2015 Jun; 43(4):558-68. PubMed ID: 25398757
[TBL] [Abstract][Full Text] [Related]
19. Activation of PPARα decreases bile acids in livers of female mice while maintaining bile flow and biliary bile acid excretion.
Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
Toxicol Appl Pharmacol; 2018 Jan; 338():112-123. PubMed ID: 29175453
[TBL] [Abstract][Full Text] [Related]
20. Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPARα mice fed an American diet.
Schlezinger JJ; Hyötyläinen T; Sinioja T; Boston C; Puckett H; Oliver J; Heiger-Bernays W; Webster TF
Toxicol Appl Pharmacol; 2021 Sep; 426():115644. PubMed ID: 34252412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
